Astoriom acquires additional UK storage business to expand capacity and service offerings
• Acquisition of Sampled’s UK facility strengthens Astoriom’s position as a trusted provider of secure, compliant and quality-led sample stability and biorepository storage solutions • Offers broader coverage, additional technical expertise and increased operational resilience to help safeguard critical samples
How does lead design affect MRI compatibility?
A smarter way to design MRI-safe implants: Evaluating MRI-induced RF heating earlier with efficient transfer-function modelling
Eppendorf introduces the new SpinPro® 8 R high-speed centrifuge
Eppendorf, a leading international life science company that develops, manufactures, and distributes instruments, consumables, and services for use in laboratories around the world, today announced the expansion of its centrifuge portfolio with the launch of the new SpinPro 8 R, a refrigerated, f
What AI in life sciences looks like up close
Reflections from the Cambridge TechBio Caucus working lunch during Cambridge Tech Week.
The EpiCentre welcomes new cancer diagnostics company 4fold Bioscience
A biotechnology start-up company, developing a low-cost diagnostic platform designed to accurately identify early-stage cancers , has chosen The EpiCentre in Haverhill as the base for its next stage of development
Nuclera appoints Carl Raimond as Chief Executive Officer
Former Olink Proteomics President brings extensive life-science tools leadership experience, having helped lead Olink through its $3.1 billion acquisition by Thermo Fisher Scientific Co-founder and former CEO Dr Michael Chen transitions to Chief Scientific and Busi
ROAR Events Agency and Holiday Inn Cambridge launch a summer party partnership for 2027
Cambridge, UK – September 2026 – ROAR Events Agency has announced a new partnership with Holiday Inn Cambridge to deliver a programme of large-scale corporate summer parties and outdoor events throughout May to September 2027.
CellCentric wins Business of the Year at 36th Business Weekly Awards ahead of tipped US IPO
Tony Quested writes: CEO Will West winged in from New York as his company CellCentric won the 36th annual Business Weekly Awards' coveted Business of the Year crown at Queens' College.
What does it take to build a world-class company in the UK?
The UK has no shortage of great ideas. The harder question is whether we have the capital, people and appetite for risk to turn more of them into world-class companies that grow and stay here.
Big Picture Bio founded to identify, design and optimise promising cancer combination therapies
New company founded by Deep Science Ventures veterans closes £1.5M (~$2M USD) pre-seed round and secures £700K (~$950K USD) Innovate UK fundingFounding team and advisors bring expertise from Deep Science Ventures, AstraZeneca, Exscientia and PhoreMostI
Acquisition of Corazon Health by HCML
Corazon Health announced today that it has been acquired by HCML, a leading provider of health, rehabilitation, case management, and treatment services.
Research Roundup: Summer 2026
Welcome to our new research roundup. Each quarter we will highlight new research publications that include the NIHR BioResource and our participants. We have summarised each publication below, including links to the journal and any associated news articles.
Fuse Diagnostics raises £1 million to scale rapid point-of-need molecular testing platform
Financing will accelerate commercialisation of Fuse Diagnostics’ proprietary Flip platform, expanding its portfolio of rapid, laboratory-quality molecular diagnostics for high-value industrial and life science applicationsInvestment led by The FSE Group alongside existi
Blood markers linked to specific types of stroke identified by Cambridge researchers
Researchers at the University of Cambridge have identified two key chemical markers in the blood that are directly linked to different types of stroke caused by small vessel disease in the brain. The discovery could pave the way for earlier diagnosis, better disease tracking, and more targeted treatments in the future.
Why Life Science and Biotech companies struggle to connect marketing activity to pipeline
Many Life Science and Biotech organisations invest significantly in lead generation but find it difficult to demonstrate a clear link between marketing activity and revenue outcomes.
Charity seeks half-marathon runners for March 27
Charity seeks people who like a challenge to join their Cambridge Half Marathon Team on 14th March 2027
East Anglian Air Ambulance supporters take on Trek 24 in Cambridge
The first-ever Trek 24 Cambridgeshire took place on Sunday 6 September, raising vital funds to support East Anglian Air Ambulance and help secure the future of its lifesaving service across the region – with 150 people taking part in the event.
Impact of childhood chemotherapy on healthy tissues uncovered
The amount of DNA damage caused by certain chemotherapies used to effectively treat childhood cancer has been revealed, along with a hidden impact on the liver. The findings pave the way for future research into new ways to mitigate these impacts.
Dragon Boat teams smash fundraising target with £50,000+ raised for new Cambridge Cancer Research Hospital
This year's Cambridge Dragon Boat Festival saw a day of firsts, a day of celebrations and a day of coming together to remember why everyone involved was taking part.
EpilepsyGTx and Viralgen collaborate to advance AAV gene therapy programme for epilepsy ahead of first-in-human trial
Collaboration with AAV-specialist CDMO will support scalable production of EPY201 for focal refractory epilepsy affecting 10 million people
Yourgene Health Insight DPYD Assay Achieves IVDR Accreditation
Comprehensive pharmacogenetic testing solution aligned with latest clinical guidance to support informed chemotherapy treatment decisions.
Guardtech donate to golf day fundraiser to cap off a series of donations close to business’ heart
The East Anglian cleanroom construction specialists have donated £440 towards the Sarcoma UK Golf Day fundraiser as the latest instalment of their ongoing Charity Champions initiative
Rational VHH Humanisation: Keeping the binder you started with
Isogenica's latest case study shows how a structure-guided, iterative approach to VHH humanisation can push nanobodies to 80%+ human-likeness while retaining antigen binding, expression and stability, avoiding the common pitfall of trading away a good binder's properties in pursuit of sequence identity alone.
Eppendorf launches new refrigerated Centrifuge 5811 R
Hamburg, Germany, 8 September, 2026 – Eppendorf, a leading international life science company that develops, manufactures, and distributes instruments, consumables, and services for use in laboratories around the world, today announced the launch of the Centrifuge 5811